Clinical Trials
1,271 trialsNasal Inhalation of Isopropyl Alcohol for the Treatment of Nausea in Patients With Cancer
M.D. Anderson Cancer Center
Assessing Administration of pBI-11 Via Electroporation for the Treatment of Patients With HPV16/18+
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
REVIVE
Asan Medical Center
NEST3
City of Hope Medical Center
RAVEN
UNC Lineberger Comprehensive Cancer Center
Xiaochaihu Granules for Depression After Allogeneic Hematopoietic Stem Cell Transplantation
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase II Trial of Zanzalitinib in Patients With Metastatic Castration Resistant Prostate Cancer
Case Comprehensive Cancer Center
Hypofractionated Chemoradiotherapy With Tislelizumab and Surufatinib for Unresectable Stage III NSCLC
Sun Yat-sen University
IGFBP-2 Vaccine to Prevent Ovarian Cancer Progression in Patients With Serologic Detection of Recurrence
University of Washington
CURB-TKI
University Health Network, Toronto
OPTICAL-3
Sun Yat-sen University
FLINN
Washington University School of Medicine
Neoadjuvant PD-L1 Inhibitor Plus Anlotinib for Kidney Preservation in Complex Renal Cell Carcinoma
RenJi Hospital
Metronomic Oral Paclitaxel Monotherapy and Combined Immunotherapy for Advanced HER2-Negative Breast Cancer: A Two-Stage Dose Exploration and Expansion Trial
Zhejiang Cancer Hospital
SELECTmeso
University of Southampton
TNT Esophagus
Duke University
Sintilimab Plus Chemotherapy as Induction Therapy for Unresectable Stage IIIC NSCLC
Sun Yat-sen University
REVIVE
University of Chicago
TREAT-EC
Rutgers, The State University of New Jersey
Phase 2 Study Of Nivolumab Plus AVD In Pediatric, Adolescent, And Young Adult Patients With CHL
M.D. Anderson Cancer Center
Phase 2 Study Of Mosunetuzumab In Patients With Chronic Lymphocytic Leukemia With Positive MRD
M.D. Anderson Cancer Center
Moonlanding
Vall d'Hebron Institute of Oncology
Iparomlimab Tolvorlimab as Neoadjuvant Immunotherapy for Locally Advanced Gastric Adenocarcinoma With Microsatellite Instability/Mismatch Repair Deficiency
Peking University Cancer Hospital & Institute
FT-RIC-HAPLO
Institut Paoli-Calmettes
GENE
Sir Run Run Shaw Hospital
EPIBREAST
UNICANCER
COLIBRI-GI
UNICANCER
Minoxidil With or Without Low-Level Red-Light Therapy for Improving Chemotherapy-Induced Alopecia in Breast Cancer Patients
Ohio State University Comprehensive Cancer Center
Short-Course Online Adaptive Radiotherapy Combined With Chemotherapy, Targeted Therapy and Immunotherapy as Total Neoadjuvant Therapy (TNT) for Locally Advanced Rectal Cancer
Chinese PLA General Hospital
Liposomal Irinotecan Plus Enlonstobart for Platinum-Resistant Recurrent Ovarian Cancer
Tianjin Medical University Cancer Institute and Hospital
MOMENT
Prostate Cancer Clinical Trials Consortium
Prostate Specific Membrane Antigen (PSMA) Imaging for Detection of Residual and Metastatic Prostate Cancer
Washington University School of Medicine
MARACAS
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
FC-BALANCE
Swiss Cancer Institute
GATHER
Centre Henri Becquerel
Trial Comparing LATTICE Radiotherapy vs Moderately Dose-escalated Palliative Radiation for Patients With Metastases.
Stanford University
Non-covalent BTK Inhibitor Nemtabrutinib in Combination With the CD20 Monoclonal Antibody Rituximab for the Treatment of Marginal Zone Lymphoma
City of Hope Medical Center
Epcoritamab in Combination With R-CHOP for Patients With Aggressive Non-Hodgkin Lymphoma
University of California, San Francisco
GATEWAY
Sun Yat-sen University
CUREMZL002
Institute of Hematology & Blood Diseases Hospital, China
MARGIN
Northwestern University
MRD-Adapted Low-Dose Radiation Therapy During Frontline Chemoimmunotherapy for Diffuse Large B-Cell Lymphoma
University of Nebraska
Low-dose Thoracic Radiotherapy Followed by Adebrelimab Plus Chemotherapy, and Then Sequential Maintenance Therapy With Adebrelimab for Extensive-stage Small Cell Lung Cancer
Jiangmen Central Hospital
The DoHAICs Study Expansion Phase
Tianjin Medical University Cancer Institute and Hospital
DETOXp
Montefiore Medical Center
A Clinical Study of Iparomlimab and Tuvonralimab Combined With Bevacizumab and Alternating Triweekly CAPOX/mCAPIRI Regimen as First-line Treatment for Unresectable Advanced Colorectal Cancer
Jiangsu Cancer Institute & Hospital
BBNIGC
Nanfang Hospital, Southern Medical University
Combining DCSZ11 With Radiation and Chemotherapy as Neoadjuvant Treatment for pMMR Locally Advanced Rectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
GI-05: The Impact of Olanzapine Among Patients Receiving Neoadjuvant Chemotherapy for Gastric Cancer
University of Illinois at Chicago
SPECTACLE
Fudan University